COLETTE DOLLISON: Open Payments
NPI 1063977122 · BLACKLICK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 23 payments from 9 companies in 2025. Trend: 2023 $281 · 2024 $388 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 5 | $89 |
| ViiV Healthcare Company | 3 | $86 |
| Merck Sharp & Dohme LLC | 4 | $78 |
| Aimmune Therapeutics, Inc. | 2 | $51 |
| ABBVIE INC. | 3 | $45 |
| Insmed, Inc. | 2 | $40 |
| Cumberland Pharmaceuticals, Inc. | 2 | $32 |
| Invivyd Inc | 1 | $25 |
| PFIZER INC. | 1 | $18 |
Products named: ZERBAXA, VOWST, RUKOBIA, Arikayce, DOVATO, VIBATIV, MAVYRET, PIFELTRO.
Industry payments across OH — which companies pay providers there.
